Genome-Wide Association Study Identifies Variants Associated With Progression of Liver Fibrosis From HCV Infection

Archive ouverte

Patin, Etienne | Kutalik, Zoltán | Guergnon, Julien | Bibert, Stéphanie | Nalpas, Bertrand | Jouanguy, Emmanuelle | Munteanu, Mona | Bousquet, Laurence | Argiro, Laurent | Halfon, Philippe | Boland, Anne | Müllhaupt, Beat | Semela, David | Dufour, Jean-Francois | Heim, Markus, H | Moradpour, Darius | Cerny, Andreas | Malinverni, Raffaele | Hirsch, Hans | Martinetti, Gladys | Suppiah, Vijayaprakash | Stewart, Graeme | Booth, David, J | George, Jacob | Casanova, Jean-Laurent | Brechot, Christian | Rice, Charles, M. | Talal, Andrew, H | Jacobson, Ira, M | Bourlière, Marc | Theodorou, Ioannis | Poynard, Thierry | Negro, Francesco | Pol, Stanislas | Bochud, Pierre-Yves | Abel, Laurent

Edité par CCSD ; Elsevier -

International audience. Background & Aims: Polymorphisms in IL28B were shown to affect clearance of hepatitis C virus (HCV) infection in genome-wide association (GWA) studies. Only a fraction of patients with chronic HCV infection develop liver fibrosis, a process that might also be affected by genetic factors. We performed a 2-stage GWA study of liver fibrosis progression related to HCV infection.Methods: We studied well-characterized HCV-infected patients of European descent who underwent liver biopsies before treatment. We defined various liver fibrosis phenotypes on the basis of METAVIR scores, with and without taking the duration of HCV infection into account. Our GWA analyses were conducted on a filtered primary cohort of 1161 patients using 780,650 single nucleotide polymorphisms (SNPs). We genotyped 96 SNPs with P values <5 × 10−5 from an independent replication cohort of 962 patients. We then assessed the most interesting replicated SNPs using DNA samples collected from 219 patients who participated in separate GWA studies of HCV clearance.Results: In the combined cohort of 2342 HCV-infected patients, the SNPs rs16851720 (in the total sample) and rs4374383 (in patients who received blood transfusions) were associated with fibrosis progression (Pcombined = 8.9 × 10−9 and 1.1 × 10−9, respectively). The SNP rs16851720 is located within RNF7, which encodes an antioxidant that protects against apoptosis. The SNP rs4374383, together with another replicated SNP, rs9380516 (Pcombined = 5.4 × 10−7), were linked to the functionally related genes MERTK and TULP1, which encode factors involved in phagocytosis of apoptotic cells by macrophages.Conclusions:Our GWA study identified several susceptibility loci for HCV-induced liver fibrosis; these were linked to genes that regulate apoptosis. Apoptotic control might therefore be involved in liver fibrosis.

Consulter en ligne

Suggestions

Du même auteur

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing

Archive ouverte | About, Frédégonde | CCSD

International audience. Despite the astonishing progress in treating chronic hepatitis C virus (HCV) infection with direct-acting antiviral agents, liver fibrosis remains a major health concern in HCV infected patie...

A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients

Archive ouverte | Ulveling, Damien | CCSD

International audience. There is growing evidence that human genetic variants contribute to liver fibrosis in subjects with hepatitis C virus (HCV) monoinfection, but this aspect has been little investigated in pati...

BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease

Archive ouverte | Oussalah, Abderrahim | CCSD

IF 5.008. International audience. The molecular mechanisms of hepatocellular carcinoma (HCC) carcinogenesis are still not fully understood. DNA repair defects may influence HCC risk. The aim of the study was to look...

Chargement des enrichissements...